Figure 3.
Outcomes for patients with LAR ITDpos (≤0.4) vs HAR ITDpos (>0.4) according to cooccurring risk group. (A) 5-year EFS, (B) 5-year OS, (C) 5-year relapse risk from end of induction 1.

Outcomes for patients with LAR ITDpos (≤0.4) vs HAR ITDpos (>0.4) according to cooccurring risk group. (A) 5-year EFS, (B) 5-year OS, (C) 5-year relapse risk from end of induction 1.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal